Evaxion Biotech A/S

NASDAQ: EVAX · Real-Time Price · USD
2.88
0.02 (0.70%)
At close: Aug 15, 2025, 3:59 PM
2.84
-1.39%
After-hours: Aug 15, 2025, 04:10 PM EDT

Evaxion Biotech A/S Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.05M 5.58M 13.18M 32.17M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
44K 29K 209K n/a
Other Long-Term Assets
162K 167K 156K n/a
Receivables
1.86M 1.07M n/a 1.9M
Inventory
n/a n/a -2.49M -1.9M
Other Current Assets
900K n/a n/a 637.99K
Total Current Assets
8.77M 8.35M 13.97M 34.7M
Property-Plant & Equipment
3.51M 4.34M 4.67M 5.37M
Goodwill & Intangibles
n/a n/a n/a 93K
Total Long-Term Assets
3.72M 4.54M 5.04M 5.46M
Total Assets
12.48M 12.89M -58.94M 40.16M
Account Payables
2.97M 2.69M 2.08M 2.85M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
159K 159K 136K 126K
Other Current Liabilities
927K 3.91M 1.24M 1.03M
Total Current Liabilities
4.37M 7.08M 3.76M 4.32M
Long-Term Debt
8.01M 8.49M 1.95M 1.04M
Other Long-Term Liabilities
141K 149K 6.06M 153K
Total Long-Term Liabilities
9.77M 10.53M 9.96M 3.4M
Total Liabilities
14.14M 17.62M 13.72M 7.73M
Total Debt
10.1M 10.87M 2.25M 3.69M
Common Stock
10.52M 5.9M 3.89M 3.75M
Retained Earnings
-118.54M -107.97M -72.66M -50.43M
Comprehensive Income
-3.6M -3.77M -3.65M 79.11M
Shareholders Equity
-1.65M -4.73M -72.66M -50.43M
Total Investments
44K 29K 209K n/a